Back to search resultsSummaryRMgm-1154
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene mutation |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 25565321 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Ganter M, Matuschewski K |
Name Group/Department | Parasitology Unit |
Name Institute | F-actin-capping protein subunit alpha, putative |
City | Berlin |
Country | Germany |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-1154 |
Principal name | cpα(-)::PfCPα II(1) and III(1) |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | Reduced numbers of oocysts. Oocysts produce midgut sporozoites. |
Sporozoite | Reduced numbers of oocysts. Oocysts produce midgut sporozoites. No sporozoites inside salivary glands. |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits However, the mutant shows strongly reduced numbers of oocysts in A. stephensi mosquitoes and absence of salivary gland sporozites, a phenotype which is comparable to mutants lacking expression of CPβ (RMgm-328). Combined these observations indicate that a functional CP heterodimer is necessary for normal oocyst and sporozoite development Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1243100 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0528500 | ||||||||||||||||||||||||||
Gene product | F-actin-capping protein subunit alpha, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | CPalpha, CPα | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | P. berghei cpα replacement with the complete P. falciparum cpα gene | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | For targeted disruption of PbCPα, two fragments were amplified from P. berghei genomic DNA as template using primers PbCPα_forI and PbCPα_revII to amplify the 5’ flanking region, and PbCPα_forIII and PbCPα_revIV for amplification of the 3’ flanking region. Cloning into the P. berghei transfection plasmid b3D.DT^H.^D resulted in the plasmid pPbCPαrep. In order to complement cpα(-) parasites, we amplified the orthologous P. falciparum CPα gene using the primers PfCPα_compforV and PfCPα_comprevVI and P. falciparum cDNA as template. Cloning into the plasmid pPbCPαrep resulted in the complementation plasmid pPfCPα. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |